Biotech Biogen’s Spinraza follow-up helps children with SMA who didn’t benefit from Zolgensma By James Waldron Jun 25, 2025 8:04am ...

CARLSBAD, Calif., June 25, 2025--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that its partner, Biogen, shared positive topline results from the Phase 1 study of salanersen (ION306 ...

34th Seoul Music Awards 2025 Full Winners List With Names: BTS RM and Jimin win their first award post military discharge. Heres who won what at the SMA 2025.

Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA) Atwood K. Cheung* ...

The U.S. Cybersecurity and Infrastructure Security Agency (CISA) on Wednesday added a security flaw impacting SonicWall Secure Mobile Access (SMA) 100 Series gateways to its Known Exploited ...

Spinal muscular atrophy (SMA) is a disorder affecting the motor neurons—nerve cells that control voluntary muscle movement. These cells are located in the spinal cord. Because the muscles cannot ...

Insurance denials for SMA treatments are common, particularly with employer-based insurance, leading to treatment delays and increased financial burdens. SHOW MORE ...

Sleep disorders in SMA are common and may impact your overall well-being, but improving sleep quality in SMA is possible. Medications, physical aids, and lifestyle adjustments can help you sleep ...

The SMA Reporting Standard (SMARS) has launched to address the complexities and confusion over fee structures in the separately managed accounts (SMAs) sector.

Spinal muscular atrophy (SMA) is a recessive condition that affects globally one in 14 800 newborns.1 Infants with SMA type 1 do not acquire motor milestones and rarely survive beyond the first year ...

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal stimulation.